CAR-T cell therapy for cancer causes “brain fog”
New research shows CAR-T cell therapy causes mild cognitive impairment via the same cellular mechanism as chemotherapy and respiratory infections like the flu and COVID-19. …
New research shows CAR-T cell therapy causes mild cognitive impairment via the same cellular mechanism as chemotherapy and respiratory infections like the flu and COVID-19. …
The gum disease bacterium Porphyromonas gingivalis can enter the bloodstream, infiltrate the heart, and quietly promote scar tissue buildup that distorts the heart’s structure, disrupts electrical signals, and increases the risk of atrial fibrillation. …
A newly discovered class of peptides expressed in pancreatic cancer cells could provide promising targets for T-cell therapies and other approaches to combat pancreatic tumors. …
New findings indicate that hypoglycemia may cause breakdown of the blood-retinal barrier, providing new insights into the development of diabetic retinopathy in diabetes patients. …
Researchers have identified a fat uptake mechanism in immune cells within tumors that suppresses anti-tumor immunity and have developed an antibody drug to overcome this barrier in cancer immunotherapy. …
Simultaneous disruption of lipid metabolism and KRAS-MAPK signaling eliminates pancreatic cancer tumors in preclinical human and mouse models. …
New findings reveal a mechanism that enables triple-negative breast cancer to develop therapy resistance. …
A drug typically prescribed for arthritis halts brain-damaging seizures in a mouse model of chronic epilepsy. …
Newly developed eye drops slow vision loss in animal models of retinitis pigmentosa, a group of inherited diseases that lead to progressive retinal degeneration. …
A newly developed synthetic cannabinoid compound mimics a natural molecule found in the cannabis plant, harnessing its pain-relieving properties without causing addiction or mind-altering side effects in mice. …
End of content
End of content